title: Can Thiopurines Prevent Formation of Antibodies Against Tumor Necrosis Factor Antagonists After Failure of These Therapies?
authors.affiliation: MRC Centre for Inflammation Research, Queens Medical Research Institute, Edinburgh, United Kingdom; Department of Gastroenterology, Monash Health, Melbourne, Australia.
authors.forename: Ray K
authors.initials: RK
authors.lastname: Boyapati
authors.affiliation: MRC Centre for Inflammation Research, Queens Medical Research Institute, Edinburgh, United Kingdom; Gastrointestinal Unit, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, United Kingdom.
authors.forename: Gwo-Tzer
authors.initials: GT
authors.lastname: Ho
authors.affiliation: Gastrointestinal Unit, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, United Kingdom.
authors.forename: Jack
authors.initials: J
authors.lastname: Satsangi
mesh_terms: D000917:Antibody Formation; D003424:Crohn Disease; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha
chemical_list: D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab